As well known, the adreno-sympathetic hormone - catecholamine - plays an important role in maintaining the stability of “milieu interieur”. Accordingly, a marked change may occur in catecholamine secretion in case of prolonged strenuous exercise such as marathon race where is required remarkable augmentation of cardiovascular functions. The authors had an opportunity of examining the physiological functions of all the participants in the First Tokyo International Women Marathon Race held on November 18, 1979, and collected urine samples from them before and after the race to evaluate the physiological load of the race in each woman participant by changes in urinary excretions of catecholamine metabolite (VMA) and some other substances.
As for the subjects of examinations, 19 foreign runners were 31.1 years of age on the average (ranging from 20 to 48 years) and their average Rohrer's Index was 119.0, while 33 Japanese runners were 27.8 years of age on the average (ranging from 18 to 42 years) and their average Rohrer's Index was 125.8. The urine samples at rest were collected at 8 a.m. on the day before the race after more than 10 hours fasting, and the samples after running were collected in 30 minutes after finishing the race. Just after the collections, the authors made determinations of the urine volume and pH and qualitative tests for sugar, protein, occult blood, Keton bodies and bilirubin. Then the determinations of VMA were made by Pisano's method. The resulte obtained were compared among six groups classified by the performance, viz., the order of the arrival. The classification was made as follows : 1) 1-5, 2) 6-10, 3) 11-15, 4) 16-20, 5) 21-25 and 6) 26-46. The comparison was also made between the foreigners and the Japanese.
Results:
Although there could be no significant correlation between the performance and the age or physique, the Rohrer's Index was smallest in Group 1) and largest in Group 6) .
The qualitative urine tests disclosed no marked change due to the running but protein less than 300 mg/dl was detected in the urine after running in 31 out of 40 runners. This fact seems to suggest that their physiological loads were considerably heavy. The urine volume on the average showed a decrease from 41.5 ml/hr at rest to 16.3 ml/hr after running, viz., 60.7 % decrement. The decrement was 53.2 % in the foreigners while it was 65.3 % in the Japanese. The urine volume was rather larger in Groups 5) and 6) than in the others. The urine pH on the average showed a decrease from 6.4 at rest to 5.6 after running, viz., 12.5 % decrement, and the decrement was 6.9 % in the foreigners while it was 14.9 % in the Japanese. Regarding the relation between the performance and the urine pH, there could be noted a tendency, the upper the ranking of the group, the smaller the change in pH.
The urinary excretion of VMA on the average of all the runners showed a striking increase from 155.8 mg/hr at rest to 383.1 mg/hr after the running. The increase due to running was 121.4 % in the foreigners while it was 144.1 % in the Japanese. Regarding the relation between the performance and the VMA excretion, Group 1) showed no increase in the excretion on the average, while the other groups generally showed 100 % - 200 % increase in the excretion.
On the basis of the above-mentioned findings, it was presumed that the physiological load of the marathon race was heavier in the Japanese runners than in the foreign runners, and in the lower ranking groups than in the upper ranking groups of the performance. In other words, the foreigners who showed excellent performance seemed to be highly adapted to the prolonged strenuous exercise by training and to have a regulatory mechanism of metabolism so efficient as to cope with heavy physiological load by small increase in catecholamine secretion.

This study was conducted to clarify the relationship between power estimated by blood lactate movement during intermittent running test (Maximal Anaerobic Running Test : MART), and velocity of middle distance running (V 800 m, V 1500 m) . The subjects were well-trained male middledistance runners (n=8) .
MART consisted of a variable number of 20 seconds runs on a treadmill with a 100 seconds recovery period between runs. The runs were performed ona a 4° incline. After 40 second recovery, earlobe blood samples were taken and blood lactate concentrations were analyzed. The first run was performed at 250 m/min. Velocity of the treadmill was increased by 25 m/min for each consecutive run until volitional exhaustion.
The power requirement associated with the absolute value of blood lactate (La) and relative value of peak blood lactate (PBLa) was determined from the La or %PBLa vs power curve by linear interpolation from the two consecutive La values which were above and below the desired value.
Results were summarized as follows:
(1) Maximal power (Pmax) for MART was correlated positively with V800m (r=0.880, P<0.01) and V1500m (r=0.948, p<0.001) .
(2) Power estimated at 40% value of PBLa (P40%La) correlated positively with V 1500 m (r=0.903, P<0.01), and at 60% value of PBLa (P60%La) was correlated positively with V800m (r=0.835, P<0.01) and 1500m (r=0.936, p<0.001) .
These results indicate that MART is a valid test for estimating middle distance running performance and P40%La, and P60%La are important indexes with 800-m and 1500-m running.

The in vivo muscarinic receptor binding of antimuscarinic agents (oxybutynin, solifenacin, tolterodine, and imidafenacin) used to treat urinary dysfunction in patients with overactive bladder is reviewed. Transdermal administration of oxybutynin in rats leads to significant binding of muscarinic receptors in the bladder without long-term binding in the submaxillary gland and the abolishment of salivation evoked by oral oxybutynin. Oral solifenacin shows significant and long-lasting binding to muscarinic receptors in mouse tissues expressing the M3 subtype. Oral tolterodine binds more selectively to muscarinic receptors in the bladder than in the submaxillary gland in mice. The muscarinic receptor binding of oral imidafenacin in rats is more selective and longer-lasting in the bladder than in other tissues such as the submaxillary gland, heart, colon, lung, and brain, suggesting preferential muscarinic receptor binding in the bladder. In vivo quantitative autoradiography with (+)N-[11C]methyl-3-piperidyl benzilate in rats shows significant occupancy of brain muscarinic receptors with the intravenous injection of oxybutynin, solifenacin, and tolterodine. The estimated in vivo selectivity in brain is significantly greater for solifenacin and tolterodine than for oxybutynin. Imidafenacin occupies few brain muscarinic receptors. Similar findings for oral oxybutynin were observed with positron emission tomography in conscious rhesus monkeys with a significant disturbance of short-term memory. The newer generation of antimuscarinic agents may be advantageous in terms of bladder selectivity after systemic administration.
Administration, Cutaneous ; Animals ; Autoradiography ; Benzhydryl Compounds ; Brain ; Colon ; Cresols ; Heart ; Humans ; Imidazoles ; Injections, Intravenous ; Lung ; Macaca mulatta ; Mandelic Acids ; Memory, Short-Term ; Mice ; Muscarinic Antagonists ; Phenylpropanolamine ; Positron-Emission Tomography ; Quinuclidines ; Rats ; Receptors, Muscarinic ; Salivation ; Solifenacin Succinate ; Submandibular Gland ; Tetrahydroisoquinolines ; Tolterodine Tartrate ; Urinary Bladder ; Urinary Bladder, Overactive